Outcomes of the 2021 CCIS Meeting

The third CCIS meeting focused on lessons learned in implementation science (IS) from COVID-19; and re-emerging and moving forward from the pandemic. The event featured a variety of presentations and discussion sessions, as well as pre-work prior to encourage more engagement and discussion during each virtual session meeting.

The objectives for the CCIS are:

  • Foster communication among those engaged in implementation science projects across the cancer continuum
  • Identify and develop solutions to common theoretical, methodological or empirical challenges in implementation science in cancer
  • Promote collaborative projects to fill implementation science gaps that would extend beyond a single study

Welcome, Overview of CCIS 2021


  • Robert Croyle, Ph.D., Director, Division of Cancer Control and Population Sciences, National Cancer Institute
  • Karen Emmons, Ph.D., Professor, Harvard T.H. Chan School of Public Health
  • Cynthia Vinson, Ph.D., M.P.A., Senior Advisor, Implementation Science, Division of Cancer Control and Population Sciences, National Cancer Institute

Day 1 Panel: Lessons Learned in IS from COVID-19

This panel discussion considered learning lessons from the perspective of community experience, implementation research, and non-profit/public health leadership.


  • Jennifer DeVoe, M.D., Professor and Chair, Oregon Health & Science University
  • Howard K. Koh, M.D., M.P.H., Harvey V. Fineberg Professor of the Practice of Public Health Leadership, Harvard T.H. Chan School of Public Health, Harvard Kennedy School
  • Nadia Islam, Ph.D., Associate Professor, NYU School of Medicine
  • Matthew Kreuter, Ph.D., Professor, Brown School of Social Work, Washington University in St. Louis
  • Elecia Miller, Community Coordinator, Mayor’s Health Task Force in the City of Lawrence, Massachusetts

Day 2 Panel: Re-emerging and Moving Forward from the Pandemic

This panel discussion focused on how to integrate lessons learned in pandemic recovery from the perspective of primary care delivery and financing, social justice, and community investment.


  • Simon Craddock Lee, Ph.D., M.P.H, Associate Professor, UT Southwestern Simmons Comprehensive Cancer Center
  • Michael Curry, Esq., President and CEO, Massachusetts League of Community Health Centers
  • Rebecca Etz, Ph.D., Associate Professor and Co-Director of the Larry A. Green Center, Virginia Commonwealth University
  • Erin Johnson, Vice President, Community Investment, Central Carolina Community Foundation
  • Sara Rosenbaum, JD, Professor, Milken Institute School of Public Health, George Washington University

Town Hall

In this interactive session action group leaders discussed the public goods generated from their session and provided attendees with an opportunity to prioritize actions to advance the implementation science agenda in cancer control.

Steering Committee

Prajakta Adsul, MBBS, MPH, PhD

University of New Mexico Comprehensive Cancer Center

Heather Brandt, PhD

St. Jude Children’s Research Hospital

Kathy Briant, MPH

Fred Hutch/University of Washington Cancer Consortium

David Chambers, DPhil

National Cancer Institute

Jamie Chriqui, PhD, MHS

Institute for Health Research and Policy of the University of Illinois at Chicago

Karen Emmons, PhD

Harvard T.H. Chan School of Public Health

Maria Fernandez, PhD

UT Health Science Center, Houston

Simon Craddock Lee, PhD MPH

UT Southwestern Simmons Comprehensive Cancer Center

Salene Jones, PhD

Fred Hutch/University of Washington

Alanna Rahm, PhD, MS, LGC


Donna Shelley, MD, MPH

NYU Langone Health

Rachel Shelton, ScD, MPH

Columbia University, Mailman School of Public Health

Cynthia Vinson, PhD, MPA

National Cancer Institute

Bryan Weiner, PhD

University of Washington

Stephanie Wheeler, PhD, MPH

University of North Carolina, Chapel Hill